Taysha Gene Therapies

TSHA · NASDAQ

$4.11+$0.17 (+4.31%)TodayMarket closed · Oct 20, 7:55 PM ET

Prev close $3.94

Latest news

Press releaseOct 1, 8:00 AM ETGlobe Newswire
Taysha Gene Therapies Announces Multiple Encore Presentations Supporting TSHA-102 Rett Syndrome Clinical Program at the 55th Child Neurology Society Annual Meeting
Press releaseAug 11, 4:00 PM ETGlobe Newswire
Taysha Gene Therapies Reports Second Quarter 2026 Financial Results and Provides Corporate Update
Press releaseAug 3, 8:00 AM ETGlobe Newswire
Taysha Gene Therapies and Catalent Expand Strategic Partnership to Include Future Commercial Manufacturing Support of TSHA-102 Gene Therapy for Rett Syndrome
Press releaseJun 25, 4:01 PM ETGlobe Newswire
Taysha Gene Therapies Announces Multiple Presentations Highlighting its TSHA-102 Clinical Program at the 2026 IRSF Rett Syndrome Scientific Meeting
NewsJun 25, 8:08 AM ETAvi Kapoor
H.B. Fuller, Trip.com, Hertz Global And Other Big Stocks Moving Lower In Thursday Pre-Market Session
Press releaseJun 24, 10:33 PM ETGlobe Newswire
Taysha Gene Therapies Announces Pricing of Public Offering of Common Stock and Pre-Funded Warrants
Press releaseJun 24, 4:01 PM ETGlobe Newswire
Taysha Gene Therapies Announces Proposed Public Offering of Common Stock and Pre-Funded Warrants
Press releaseJun 22, 8:00 AM ETGlobe Newswire
Taysha Gene Therapies Announces Completion of Dosing in REVEAL Pivotal Trial and Reports Longer-Term Clinical Data from Part A of REVEAL Phase 1/2 Trials Evaluating TSHA-102 for Rett Syndrome
NewsMay 6, 5:03 PM ET
Earnings Scheduled For May 6, 2026
Press releaseMay 6, 8:00 AM ETGlobe Newswire
Taysha Gene Therapies Reports First Quarter 2026 Financial Results and Provides Corporate Update
Press releaseApr 27, 5:21 PM ETGlobe Newswire
Taysha Gene Therapies to Present New Preclinical Data Supporting Construct Design of TSHA-102 for Rett Syndrome at the ASGCT 2026 Annual Meeting
Press releaseMar 19, 8:00 AM ETGlobe Newswire
Taysha Gene Therapies Reports Full-Year 2025 Financial Results and Provides Corporate Update
NewsMar 19, 7:11 AM ET
Earnings Scheduled For March 19, 2026
Press releaseNov 4, 7:00 AM ETGlobe Newswire
Taysha Gene Therapies Reports Third Quarter 2025 Financial Results and Provides Corporate Update
NewsNov 4, 6:12 AM ET
Earnings Scheduled For November 4, 2025
Press releaseOct 28, 8:00 AM ETGlobe Newswire
Taysha Gene Therapies to Release Third Quarter 2025 Financial Results and Host Conference Call and Webcast on November 4
NewsOct 20, 8:10 AM ETAvi Kapoor
Olema Pharmaceuticals, Exelixis, Genmab And Other Big Stocks Moving Lower In Monday's Pre-Market Session
Press releaseOct 9, 8:00 AM ETGlobe Newswire
Taysha Gene Therapies Presents New Supplemental Data Analysis from Part A of the REVEAL Phase 1/2 Trials for TSHA-102 in Rett Syndrome at the 54th CNS Annual Meeting
NewsOct 2, 2:01 PM ET
Demystifying Taysha Gene Therapies: Insights From 6 Analyst Reviews
NewsOct 2, 12:29 PM ETAvi Kapoor
Taysha Gene Therapies, Canaan, Ondas Holdings And Other Big Stocks Moving Higher On Thursday
NewsAug 13, 9:00 AM ET
A Glimpse Into The Expert Outlook On Taysha Gene Therapies Through 11 Analysts
Press releaseAug 12, 8:01 AM ETGlobe Newswire
Taysha Gene Therapies Reports Second Quarter 2025 Financial Results and Provides Corporate Update
NewsAug 12, 4:32 AM ET
Earnings Scheduled For August 12, 2025
NewsAug 11, 12:02 PM ET
What's Next: Taysha Gene Therapies's Earnings Preview
Press releaseAug 5, 4:05 PM ETGlobe Newswire
Taysha Gene Therapies to Release Second Quarter 2025 Financial Results and Host Conference Call and Webcast on August 12
NewsJul 1, 8:04 AM ET
Beyond The Numbers: 10 Analysts Discuss Taysha Gene Therapies Stock
NewsJun 2, 3:00 PM ET
Where Taysha Gene Therapies Stands With Analysts
NewsMay 29, 8:07 AM ET
12 Health Care Stocks Moving In Thursday's Pre-Market Session
NewsMay 16, 10:00 AM ET
Expert Outlook: Taysha Gene Therapies Through The Eyes Of 6 Analysts
NewsMay 15, 5:05 PM ET
12 Health Care Stocks Moving In Thursday's After-Market Session
Press releaseMay 8, 4:05 PM ETGlobe Newswire
Taysha Gene Therapies to Release First Quarter 2025 Financial Results and Host Conference Call and Webcast on May 15
Press releaseFeb 19, 8:00 AM ETGlobe Newswire
Taysha Gene Therapies to Release Full-Year 2024 Financial Results and Host Conference Call and Webcast on February 26
NewsJan 6, 3:00 PM ET
Assessing Taysha Gene Therapies: Insights From 8 Financial Analysts
NewsNov 15, 10:00 AM ET
Expert Outlook: Taysha Gene Therapies Through The Eyes Of 7 Analysts
NewsNov 14, 8:25 AM ETAvi Kapoor
Advance Auto Parts Posts Weak Results, Joins Harrow, Taysha Gene Therapies And Other Big Stocks Moving Lower In Thursday's Pre-Market Session
NewsNov 14, 5:12 AM ETAvi Kapoor
Why DLocal Shares Are Trading Higher By Around 18%; Here Are 20 Stocks Moving Premarket
NewsNov 12, 4:08 PM ET
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
NewsNov 12, 2:31 PM ETAvi Kapoor
Dow Dips Over 200 Points; Home Depot Posts Upbeat Earnings
NewsNov 12, 2:27 PM ETAvi Kapoor
Tyson Foods Posts Better-Than-Expected Earnings, Joins Shopify, Sea, Buckle And Other Big Stocks Moving Higher On Tuesday
NewsNov 12, 1:08 PM ET
Preview: Taysha Gene Therapies's Earnings
Press releaseNov 6, 8:00 AM ETGlobe Newswire
Taysha Gene Therapies to Release Third Quarter 2024 Financial Results and Host Conference Call and Webcast On November 13
NewsAug 12, 2:00 PM ET
Peeling Back The Layers: Exploring Taysha Gene Therapies Through Analyst Insights
Press releaseAug 5, 8:00 AM ETGlobe Newswire
Taysha Gene Therapies to Release Second Quarter 2024 Financial Results and Host Conference Call and Webcast on August 12
NewsJul 23, 8:03 AM ET
Where Taysha Gene Therapies Stands With Analysts

Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.

Latest news

Taysha Gene Therapies Announces Multiple Encore Presentations Supporting TSHA-102 Rett Syndrome Clinical Program at the 55th Child Neurology Society Annual Meeting

Taysha Gene Therapies Reports Second Quarter 2026 Financial Results and Provides Corporate Update

Taysha Gene Therapies and Catalent Expand Strategic Partnership to Include Future Commercial Manufacturing Support of TSHA-102 Gene Therapy for Rett Syndrome

Taysha Gene Therapies Announces Multiple Presentations Highlighting its TSHA-102 Clinical Program at the 2026 IRSF Rett Syndrome Scientific Meeting

H.B. Fuller, Trip.com, Hertz Global And Other Big Stocks Moving Lower In Thursday Pre-Market Session

Taysha Gene Therapies Announces Pricing of Public Offering of Common Stock and Pre-Funded Warrants

Taysha Gene Therapies Announces Proposed Public Offering of Common Stock and Pre-Funded Warrants

Taysha Gene Therapies Announces Completion of Dosing in REVEAL Pivotal Trial and Reports Longer-Term Clinical Data from Part A of REVEAL Phase 1/2 Trials Evaluating TSHA-102 for Rett Syndrome

Earnings Scheduled For May 6, 2026

Taysha Gene Therapies Reports First Quarter 2026 Financial Results and Provides Corporate Update

Taysha Gene Therapies to Present New Preclinical Data Supporting Construct Design of TSHA-102 for Rett Syndrome at the ASGCT 2026 Annual Meeting

Taysha Gene Therapies Reports Full-Year 2025 Financial Results and Provides Corporate Update

Earnings Scheduled For March 19, 2026

Taysha Gene Therapies Reports Third Quarter 2025 Financial Results and Provides Corporate Update

Earnings Scheduled For November 4, 2025

Taysha Gene Therapies to Release Third Quarter 2025 Financial Results and Host Conference Call and Webcast on November 4

Olema Pharmaceuticals, Exelixis, Genmab And Other Big Stocks Moving Lower In Monday's Pre-Market Session

Taysha Gene Therapies Presents New Supplemental Data Analysis from Part A of the REVEAL Phase 1/2 Trials for TSHA-102 in Rett Syndrome at the 54th CNS Annual Meeting

Demystifying Taysha Gene Therapies: Insights From 6 Analyst Reviews

Taysha Gene Therapies, Canaan, Ondas Holdings And Other Big Stocks Moving Higher On Thursday

A Glimpse Into The Expert Outlook On Taysha Gene Therapies Through 11 Analysts

Taysha Gene Therapies Reports Second Quarter 2025 Financial Results and Provides Corporate Update

Earnings Scheduled For August 12, 2025

What's Next: Taysha Gene Therapies's Earnings Preview

Taysha Gene Therapies to Release Second Quarter 2025 Financial Results and Host Conference Call and Webcast on August 12

Beyond The Numbers: 10 Analysts Discuss Taysha Gene Therapies Stock

Where Taysha Gene Therapies Stands With Analysts

12 Health Care Stocks Moving In Thursday's Pre-Market Session

Expert Outlook: Taysha Gene Therapies Through The Eyes Of 6 Analysts

12 Health Care Stocks Moving In Thursday's After-Market Session

Taysha Gene Therapies to Release First Quarter 2025 Financial Results and Host Conference Call and Webcast on May 15

Taysha Gene Therapies to Release Full-Year 2024 Financial Results and Host Conference Call and Webcast on February 26

Assessing Taysha Gene Therapies: Insights From 8 Financial Analysts

Expert Outlook: Taysha Gene Therapies Through The Eyes Of 7 Analysts

Advance Auto Parts Posts Weak Results, Joins Harrow, Taysha Gene Therapies And Other Big Stocks Moving Lower In Thursday's Pre-Market Session

Why DLocal Shares Are Trading Higher By Around 18%; Here Are 20 Stocks Moving Premarket

12 Health Care Stocks Moving In Tuesday's Pre-Market Session

Dow Dips Over 200 Points; Home Depot Posts Upbeat Earnings

Tyson Foods Posts Better-Than-Expected Earnings, Joins Shopify, Sea, Buckle And Other Big Stocks Moving Higher On Tuesday

Preview: Taysha Gene Therapies's Earnings

Taysha Gene Therapies to Release Third Quarter 2024 Financial Results and Host Conference Call and Webcast On November 13

Peeling Back The Layers: Exploring Taysha Gene Therapies Through Analyst Insights

Taysha Gene Therapies to Release Second Quarter 2024 Financial Results and Host Conference Call and Webcast on August 12

Where Taysha Gene Therapies Stands With Analysts